Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
10.1016/j.bbrc.2013.03.010 15
Li, Y., Liu, Y., Wu, T., Kenaan, A., Geng, F., Li, B., Gunaratne, A., Li, H., & Gan, Y
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 118,99 per year only 9,92 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
PlexusDx clinicians personalize your dosing plan to minimize side effects from day one
The FDA has evaluated BPC-157 as a bulk drug substance for compounding and raised questions about its safety data
Get started with an online consultation and begin treatment with medications designed around these powerful metabolic hormones
US$ 21.12
US$ 27.08
/assets/images/provider/photos/2798511.png)
US$ 21.16
:max_bytes(150000):strip_icc():focal(917x448:919x450)/Leslie-Gammon-71626-556424c04eb94597849027cd93574b72.jpg)
US$ 25.30
